About Theradaptive
Theradaptive is a company based in Boston (United States) founded in 2004. Theradaptive has raised $68.36 million across 7 funding rounds from investors including TEDCO, ORTHOREBIRTH and Maryland Stem Cell Research Fund. The company has 21 employees as of December 31, 2022. Theradaptive offers products and services including Protein Engineering Platform, OASIS Trial, and Preclinical Studies. Theradaptive operates in a competitive market with competitors including MiMedx Group, Ossio, EpiBone, Biocomposites and CartiHeal, among others.
- Headquarter Boston, United States
- Employees 21 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Theradaptive, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$68.36 M (USD)
in 7 rounds
-
Latest Funding Round
$36.16 M (USD), Series B
Jul 21, 2026
-
Investors
TEDCO
& 4 more
-
Employee Count
21
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Theradaptive
Theradaptive offers a comprehensive portfolio of products and services, including Protein Engineering Platform, OASIS Trial, and Preclinical Studies.
Develops modified proteins for targeted therapeutic delivery in clinical applications.
Conducts trials for protein-based therapeutics in medical treatments.
Performs studies on protein variants for various indications.
People of Theradaptive
Unlock access to complete
Funding Insights of Theradaptive
Theradaptive has successfully raised a total of $68.36M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $36.16 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Theradaptive
Theradaptive has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include TEDCO, ORTHOREBIRTH and Maryland Stem Cell Research Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stem cell research startups in healthcare are funded and accelerated.
|
Locked | Locked | Locked | |
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Locked | Locked | Locked | |
|
Cottony type synthetic bone void filling material
|
Locked | Locked | Locked |
Investor details for Theradaptive
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Theradaptive
Investment portfolio details for Theradaptive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Theradaptive
Detailed financials for Theradaptive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Theradaptive Comparisons
Peer comparison for Theradaptive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Theradaptive
Theradaptive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, EpiBone, Biocomposites and CartiHeal, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
|
| Locked | Locked | Locked |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| Locked | Locked | Locked |
Implants for bone and cartilage regeneration are developed and provided.
|
Detailed competitors of Theradaptive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Theradaptive
Complete news archive for Theradaptive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Theradaptive
Theradaptive was founded in 2004 and raised its 1st funding round 14 years after it was founded.
Theradaptive is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Theradaptive is a funded company, having raised a total of $68.36M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Theradaptive is 21.
Theradaptive was founded in 2004 and is headquartered in Boston, United States. A therapeutic delivery platform is developed for various orthopedic clinical indications within the biotechnology sector. Solutions are offered for conditions such as spinal fusion, trauma repair, dental repair, and complex cartilage repair. Therapeutics are delivered to support targeted native tissue repair across multiple applications.
Theradaptive's top competitors include EpiBone, MiMedx Group and Ossio.
Theradaptive offers Protein Engineering Platform, OASIS Trial, and Preclinical Studies.
Theradaptive has 5 investors. Key investors include TEDCO, ORTHOREBIRTH, Maryland Stem Cell Research Fund, U.S. Department of Defense, and Military Health.